How many courses of treatment is needed for Jisandai (Bingtonsha)?
Epclusa (Epclusa) is a drug widely used to treat hepatitis C, containing sofosbuvir (Sofosbuvir) and velpatasvir (Velpatasvir). Treatment plans usually include a standard course of treatment, but the length of the course may vary based on the individual patient's circumstances.
For most patients with hepatitis C, the recommended treatment cycle of GISANDA is 12 weeks. This course of treatment has been shown in clinical trials to effectively clear the hepatitis C virus from the body and significantly improve cure rates. 12weeks of treatment are suitable for most patients, including those infected with the major HCV genotypes (e.g., 1, 2 type, 3 type and 4 type) patients.

In some cases, treatment options may be adjusted. For patients with specific disease backgrounds or complications, doctors may adjust the course of treatment based on the patient's specific conditions. For example, in patients with cirrhosis or severely impaired liver function, treatment may be longer to ensure complete clearance of the virus.
The treatment course of Jisandai (Bingtonsha) is designed to maximize the therapeutic effect while minimizing side effects. 12A course of treatment can effectively control hepatitis C virus and help patients achieve sustained virological response (SVR), that is, the virus remains undetectable 6 months after the end of treatment, which marks a cure.
It should be noted that during treatment, patients should take medications on time and must not miss doses. Treatment compliance is critical to achieving good treatment outcomes. If side effects or discomfort occur during treatment, you should communicate with your doctor in time so that the treatment plan can be adjusted as needed.
In some cases, doctors may recommend additional treatments if a patient is not fully healed after completing the standard 12week course of treatment. At this time, the doctor may choose to continue treatment or change other drug combinations according to the specific situation to improve the treatment effect.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)